MedPath

PRIMAL CHEMICAL COMPANY, LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

46

PPB:46

Drug Approvals

FLUTICASONE FUROATE NITTO NASAL SPRAY 27.5MCG/SPRAY

Approval Date
Jun 25, 2025
PPB

ELLANITE TABLETS 0.03MG/3MG

Approval Date
Jun 25, 2024
PPB

LATACHIMO COMBINATION OPHTHALMIC SOLUTION

Approval Date
Oct 3, 2023
PPB

TRAVOPROST OPHTHALMIC SOLUTION 0.004% W/V

Approval Date
Dec 21, 2022
PPB

TRICLOFEM SUSPENSION FOR INJECTION 150MG/1ML

Approval Date
Nov 24, 2021
PPB

LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V

Approval Date
Apr 1, 2021
PPB

METPHAR XR 750 EXTENDED-RELEASE TABLETS 750MG

Approval Date
Oct 30, 2020
PPB

SUNPEPCIN 20 TABLETS 20MG

Approval Date
Feb 8, 2019
PPB

SUNOSYN SYRUP 3MG/5ML

Approval Date
Jan 28, 2019
PPB

MEDROGOT TABLETS 5MG

Approval Date
Aug 25, 2014
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.